<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shabatina TI</submitter><funding>Russian Science Foundation</funding><pagination>1588</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8235636</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(6)</volume><pubmed_abstract>Increasing the effectiveness of known, well-tested drugs is a promising low-cost alternative to the search for new drug molecular forms. Powerful approaches to solve this problem are (a) an active drug particle size reduction down to the nanoscale and (b) thermodynamically metastable but kinetically stable crystal modifications of drug acquisition. The combined cryochemical method has been used for size and structural modifications of the antibacterial drug 2,3-quinoxalinedimethanol-1,4-dioxide (dioxidine). The main stage of the proposed technique includes the formation of a molecular vapor of the drug substance, combined with a carrier gas (CO2) flow, followed by a fast condensation of the drug substance and CO2 molecules on a cooled-by-liquid nitrogen surface of preparative cryostate. It</pubmed_abstract><journal>Nanomaterials (Basel, Switzerland)</journal><pubmed_title>Cryochemical Production of Drug Nanoforms: Particle Size and Crystal Phase Control of the Antibacterial Medication 2,3-Quinoxalinedimethanol-1,4-dioxide (Dioxidine).</pubmed_title><pmcid>PMC8235636</pmcid><funding_grant_id>16-13-10365</funding_grant_id><pubmed_authors>Shabatina TI</pubmed_authors><pubmed_authors>Soloviev AV</pubmed_authors><pubmed_authors>Shabatin AV</pubmed_authors><pubmed_authors>Melnikov MY</pubmed_authors><pubmed_authors>Morosov YN</pubmed_authors><pubmed_authors>Vernaya OI</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cryochemical Production of Drug Nanoforms: Particle Size and Crystal Phase Control of the Antibacterial Medication 2,3-Quinoxalinedimethanol-1,4-dioxide (Dioxidine).</name><description>Increasing the effectiveness of known, well-tested drugs is a promising low-cost alternative to the search for new drug molecular forms. Powerful approaches to solve this problem are (a) an active drug particle size reduction down to the nanoscale and (b) thermodynamically metastable but kinetically stable crystal modifications of drug acquisition. The combined cryochemical method has been used for size and structural modifications of the antibacterial drug 2,3-quinoxalinedimethanol-1,4-dioxide (dioxidine). The main stage of the proposed technique includes the formation of a molecular vapor of the drug substance, combined with a carrier gas (CO2) flow, followed by a fast condensation of the drug substance and CO2 molecules on a cooled-by-liquid nitrogen surface of preparative cryostate. It</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jun</publication><modification>2025-04-19T17:44:09.511Z</modification><creation>2022-02-10T19:29:49.305Z</creation></dates><accession>S-EPMC8235636</accession><cross_references><pubmed>34204303</pubmed><doi>10.3390/nano11061588</doi></cross_references></HashMap>